People · Operator

JACK LIEF

Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology

1
Companies
2
Filings
$187.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Arena Pharmaceuticals IncBiotechnologySeries D+$187.3M$1.5B2009
Operator network

JACK LIEF at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Tina S. Nova · 3 companies · 1 sharedTina S. NovaChristine A. White · 2 companies · 1 sharedChristine A. WhiteRandall E. Woods · 2 companies · 1 sharedRandall E. WoodsRobert E. Hoffman · 2 companies · 1 sharedRobert E. HoffmanDOMINIC P. BEHAN · 1 companies · 1 sharedDOMINIC P. BEHANDONALD D. BELCHER · 1 companies · 1 sharedDONALD D. BELCHERHARRY F. HIXSON, JR. · 1 companies · 1 sharedHARRY F. HIXSON, …J. CLAYBURN LA FORCE, JR. · 1 companies · 1 sharedJ. CLAYBURN LA FO…K.A. AJIT-SIMH · 1 companies · 1 sharedK.A. AJIT-SIMHPHILLIP M. SCHNEIDER · 1 companies · 1 sharedPHILLIP M. SCHNEI…SCOTT H. BICE · 1 companies · 1 sharedSCOTT H. BICESTEVEN W. SPECTOR · 1 companies · 1 sharedSTEVEN W. SPECTORWILLIAM R. SHANAHAN, JR. · 1 companies · 1 sharedWILLIAM R. SHANAH…Arena Pharmaceuticals Inc · $187.3M raisedArena Pharmaceuticals…JACK LIEFJL
JACK LIEF Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside JACK LIEF on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Tina S. Nova13
Randall E. Woods12
Robert E. Hoffman12
Christine A. White12
DOMINIC P. BEHAN11
J. CLAYBURN LA FORCE, JR.11
K.A. AJIT-SIMH11
SCOTT H. BICE11
WILLIAM R. SHANAHAN, JR.11
PHILLIP M. SCHNEIDER11
DONALD D. BELCHER11
STEVEN W. SPECTOR11
HARRY F. HIXSON, JR.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.